Compare MRVI & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | CMP |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 999.1M |
| IPO Year | 2020 | 2003 |
| Metric | MRVI | CMP |
|---|---|---|
| Price | $7.48 | $22.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $4.13 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 2.6M | 343.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | ★ $185,743,000.00 | N/A |
| Revenue This Year | $12.54 | N/A |
| Revenue Next Year | $7.87 | $1.29 |
| P/E Ratio | ★ N/A | $38.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.55 | $16.40 |
| 52 Week High | $9.42 | $34.50 |
| Indicator | MRVI | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 30.33 |
| Support Level | $5.54 | $22.23 |
| Resistance Level | $9.42 | $26.72 |
| Average True Range (ATR) | 0.36 | 0.63 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 79.22 | 5.38 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.